Factors associated with DAA virological treatment failure and resistance-associated substitutions description in HIV/HCV coinfected patients

AIM: To describe factors associated with treatment failure and frequency of resistance-associated substitutions (RAS). METHODS: Human immunodeficiency virus (HIV)/hepatitis C virus (HCV) coinfected patients starting a first direct-acting antiviral (DAA) regimen before February 2016 and included in t...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:World J Hepatol
Autori principali: Salmon, Dominique, Trimoulet, Pascale, Gilbert, Camille, Solas, Caroline, Lafourcade, Eva, Chas, Julie, Piroth, Lionel, Lacombe, Karine, Katlama, Christine, Peytavin, Gilles, Aumaitre, Hugues, Alric, Laurent, Boué, François, Morlat, Philippe, Poizot-Martin, Isabelle, Billaud, Eric, Rosenthal, Eric, Naqvi, Alissa, Miailhes, Patrick, Bani-Sadr, Firouzé, Esterle, Laure, Carrieri, Patrizia, Dabis, François, Sogni, Philippe, Wittkop, Linda
Natura: Artigo
Lingua:Inglês
Pubblicazione: Baishideng Publishing Group Inc 2018
Soggetti:
Observational Study
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6280155/
https://ncbi.nlm.nih.gov/pubmed/30533186
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4254/wjh.v10.i11.856
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi